FMP
NASDAQ
2.84 USD
0.08 (2.82%)
Mr. Gary S. Gillheeney Sr.
Healthcare
Drug Manufacturers - Specialty & Generic
https://organogenesis.com
NASDAQ
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediat...
0001661181
US68621F1021
68621F102
85 Dan Road
781 575 0775
US
862
Jan 5, 2017
0001661181
NASDAQ
Drug Manufacturers -...
Healthcare
68621F102
US68621F1021
US
2.84
1.58
691.05k
374.77M
-
1.795-4.705
-2.49
-
-
-
-
71
-
https://organogenesis.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.